Product Code: ETC6189576 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The quinolones market in Australia is characterized by the growing use of these broad-spectrum antibiotics in treating various bacterial infections. Quinolones are particularly effective against respiratory tract infections, urinary tract infections, and skin infections, among others. With an increasing incidence of antibiotic-resistant bacteria, quinolones remain a significant therapeutic option in Australia`s healthcare system. The market`s growth is bolstered by advancements in the pharmaceutical industry, including the development of newer quinolone derivatives with improved safety and efficacy profiles. However, concerns about antibiotic resistance and the overuse of antibiotics may impact the market`s future, with more emphasis on responsible usage.
The quinolones market in Australia is growing steadily due to their extensive use as antibiotics for treating bacterial infections. Quinolones, which include popular drugs such as ciprofloxacin and levofloxacin, are highly effective against a wide range of infections. The demand for these drugs is influenced by the rising incidence of bacterial diseases, particularly in the aging population. However, there is also growing concern over antibiotic resistance, which may affect the market dynamics of quinolones. Increased regulation and efforts to combat antibiotic resistance might lead to shifts in how quinolones are prescribed and used, potentially impacting their market growth.
The Quinolones market in Australia faces challenges in terms of rising concerns over antibiotic resistance. Quinolones, often used as broad-spectrum antibiotics, are increasingly subject to stricter regulations due to their potential role in promoting resistance. This has led to limited prescriptions and a reduction in their market share. Additionally, newer and more targeted antibiotics are replacing quinolones in many clinical settings, reducing the demand. There is also increasing public awareness and concern about the overuse of antibiotics, which impacts the market growth.
The quinolones market in Australia is supported by policies aimed at advancing pharmaceutical innovation, particularly for antibiotics and antimicrobial treatments. The Australia government offers tax incentives and subsidies for pharmaceutical companies conducting R&D on new quinolone-based drugs or improving production efficiencies. Policies also emphasize strengthening the domestic manufacturing capabilities for quinolones, particularly in response to growing global concerns about antibiotic resistance. The government supports collaborations between universities, research institutions, and pharmaceutical companies to accelerate the development and commercialization of new quinolone therapies.
The Australia government enforces strict regulations on the use of antibiotics and pharmaceutical products, including quinolones, through the Therapeutic Goods Administration (TGA). Policies to prevent the misuse of antibiotics, promote appropriate prescribing practices, and ensure the quality and safety of medicines directly impact the quinolones market. Additionally, ongoing government initiatives aimed at controlling antimicrobial resistance (AMR) have influenced market dynamics by encouraging responsible usage and the development of alternative treatments.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Quinolones Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Quinolones Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Quinolones Market - Industry Life Cycle |
3.4 Australia Quinolones Market - Porter's Five Forces |
3.5 Australia Quinolones Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Australia Quinolones Market Revenues & Volume Share, By Pathogen Type, 2021 & 2031F |
3.7 Australia Quinolones Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Australia Quinolones Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Australia Quinolones Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Australia Quinolones Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Quinolones Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Quinolones Market Trends |
6 Australia Quinolones Market, By Types |
6.1 Australia Quinolones Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Quinolones Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Australia Quinolones Market Revenues & Volume, By Urinary Tract Infection, 2021- 2031F |
6.1.4 Australia Quinolones Market Revenues & Volume, By Intra-Abdominal Infections, 2021- 2031F |
6.1.5 Australia Quinolones Market Revenues & Volume, By Blood Stream Infections, 2021- 2031F |
6.1.6 Australia Quinolones Market Revenues & Volume, By Clostridium Difficile Infections, 2021- 2031F |
6.2 Australia Quinolones Market, By Pathogen Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Quinolones Market Revenues & Volume, By Gram-Positive Pathogen, 2021- 2031F |
6.2.3 Australia Quinolones Market Revenues & Volume, By Gram-Negative Pathogen, 2021- 2031F |
6.3 Australia Quinolones Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Australia Quinolones Market Revenues & Volume, By Lomefloxacin, 2021- 2031F |
6.3.3 Australia Quinolones Market Revenues & Volume, By Gatifloxacin, 2021- 2031F |
6.3.4 Australia Quinolones Market Revenues & Volume, By Norfloxacin, 2021- 2031F |
6.3.5 Australia Quinolones Market Revenues & Volume, By Moxifloxacin, 2021- 2031F |
6.3.6 Australia Quinolones Market Revenues & Volume, By Ciprofloxacin, 2021- 2031F |
6.4 Australia Quinolones Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Australia Quinolones Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Australia Quinolones Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5 Australia Quinolones Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Australia Quinolones Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Australia Quinolones Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Australia Quinolones Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6 Australia Quinolones Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Australia Quinolones Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Australia Quinolones Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 Australia Quinolones Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Australia Quinolones Market Import-Export Trade Statistics |
7.1 Australia Quinolones Market Export to Major Countries |
7.2 Australia Quinolones Market Imports from Major Countries |
8 Australia Quinolones Market Key Performance Indicators |
9 Australia Quinolones Market - Opportunity Assessment |
9.1 Australia Quinolones Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Australia Quinolones Market Opportunity Assessment, By Pathogen Type, 2021 & 2031F |
9.3 Australia Quinolones Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Australia Quinolones Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Australia Quinolones Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 Australia Quinolones Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Quinolones Market - Competitive Landscape |
10.1 Australia Quinolones Market Revenue Share, By Companies, 2024 |
10.2 Australia Quinolones Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |